Wendy Short Bartie
West Orange
Summary
Dynamic executive with extensive leadership experience at Bristol Myers Squibb, successfully driving P&L management and achieving revenue growth of over $15B. Proven track record in strategic commercialization and talent development, continuously pursuing transformational growth opportunities to maintain a leading position in the world's largest healthcare market, specifically in Oncology. Focused on fostering equity-focused initiatives and effectively engaging cross-functional teams to achieve organizational goals. Skilled negotiator and communicator, dedicated to enhancing performance and overall organizational effectiveness. Strong background in driving business transformations and implementing operational improvements. Known for delivering strategic initiatives that foster growth and enhance profitability. Exceptional ability to foster collaborative environments and adapt to dynamic business needs sets apart in the industry.
Overview
2026
2026
years of professional experience
Work History
Senior Vice President, US Oncology and Global Stra
Bristol Myers Squibb
- Responsible for US Oncology growth strategy, integrated execution and portfolio management of BMS solid tumor and hematologic malignancies. Oversee full US Oncology portfolio strategy end to end, from pipeline entry into Ph2 development, launch and P&L management throughout in-market lifecycle. P&L responsibility for $15.5B USD and an organization of ~900 employees across different functions.
- Restructured departments for increased efficiency, optimizing resource allocation and improving communication between teams.
- Developed and executed strategic initiatives to drive business growth, resulting in higher revenues and market share expansion.
- Championed innovation by encouraging cross-functional teams to pursue creative solutions to complex challenges.
Senior Vice President and General Manager, US Hematology and Cell Therapy
Bristol Myers Squibb
- Current
- Head of BMS Hematology and Cell Therapy sales and marketing in the US
- P&L responsibility for $8B USD and an organization of ~450 employees across different functions
- Co-Chair for Inclusion and Diversity Council and Standing Member of Global Inclusion and Diversity Council
Senior Vice President and Chief of Staff, Office of the Chairman and CEO
Bristol Myers Squibb
- Current
- Provided thought partnership, research and relevant material for CEO internal Enterprise events and external meetings across a spectrum of stakeholders including Media, Investors, US policy, non-profit organizations, International governments and Trade associations
- Managed Executive committee agendas and leadership team effectiveness
- Led annual strategic objective planning for the Enterprise to achieve organizational goals
- Served as executive sponsor for CEO's G100 and GLT strategic leadership meetings
Senior Vice President, US Oncology
Bristol Myers Squibb
- Current
- Responsible for all oncology commercial operations including sales and marketing
- Accountable for developing and delivering business strategy, including full P&L responsibility
- Responsible for delivering over $6B USD in revenue annually
- Co-Chair for Diversity and Inclusion Commercialization Council
Senior Vice President, US Oncology and Global Strategy
Bristol Myers Squibb
05.2021 - Current
- Responsible for US Oncology growth strategy, integrated execution and portfolio management of BMS solid tumor and hematologic malignancies
- Oversee full US Oncology portfolio strategy end to end, from pipeline entry into Ph2 development, launch and P&L management throughout in-market lifecycle
- P&L responsibility for $15.5B USD and an organization of ~900 employees across different functions
Pharmaceutical Sales Representative
Abbott, Pharmacia, Johnson and Johnson
11.1999 - 03.2023
- Held multiple positions of increasing responsibility in the pharmaceutical sales across multiple therapeutic areas (anti-infectives, OAB, pain, epilepsy, Alzheimer's disease, Parkinson's disease and ADHD)
Associate Vice President, Global Human Health - Genitourinary Cancers
Merck Sharp & Dohme
- 07.2021
- Led commercial portfolio and pipeline Global strategy for Merck's Genitourinary Cancers portfolio
- Commercial lead on GPT responsible for development, prioritization and acceleration of early to mid-stage pipeline
- Accountable for cross-functional/cross-divisional strategy – Market Access, Supply, LCM, Business Development and Global execution with a focus on Top 10 – UK, France, Italy, Germany, Spain, Canada, USA, Japan, Brazil and China
Executive Director, Global Human Health, Women's Cancers
Merck Sharp & Dohme
- 07.2021
- Responsible for Global Strategy for Women's Cancers portfolio
- Commercial lead on GPT responsible for development, prioritization and acceleration of early to mid-stage pipeline for Breast Cancer and Gynecological Cancers
- Accountable for cross-functional/cross-divisional strategy – Market Access, Supply, LCM, Business Development and Global execution with a focus on Top 10 – UK, France, Italy, Germany, Spain, Canada, USA, Japan, Brazil and China
Director, Women's Cancer Immunotherapy
Merck Sharp & Dohme
- 07.2021
- Led Global professional commercial strategy development for Breast Cancer and Gynecological Cancers
Vice President, Commercial Operations US Oncology
Merck Sharp & Dohme
06.2016 - 07.2021
- Responsible for leading customer facing strategies for US Oncology with annual performance targets in ~$10B USD
- Led customer facing US Oncology teams including Sales, Account Management, National Account Directors, GPO Liaisons, Nurse Educators and Reimbursement Specialists
- Led market access marketing organization and pricing and policy for the US Oncology
Senior Director of Marketing
Heron Therapeutics
08.2015 - 06.2016
- Led vision and strategy to launch and drive revenue growth and profitability for Sustol
- Led commercialization strategies for HTX019 (CINV – NK1) and HTX 025 (Sustol LCM)
- Provided strategic direction for company's overall strategy based on market conditions and competitive landscape
Associate Director, Zykadia
Novartis Pharmaceuticals
- 08.2015
- Professional Promotion and Launch Lead for Zykadia, Novartis' first product to receive BTD
- Responsibilities included: Launch Readiness Lead; Professional Strategy & Materials Development Lead (Positioning/Message Development); Competition/CI; Media Planning; Field Force Design, Targeting and Incentive Strategy; FF Training Brand Lead; Field Based Strategic Team Lead and Strat Planning Lead
Associate Director, Tasigna
Novartis Pharmaceuticals
- 08.2015
- Led consumer strategy calculated to drive switch from Gleevec
- Managed A&P budget of $8M while contributing to $445M in sales (vs
- $349 PY)
- Developed and launched Novartis Oncology's first celebrity DTP campaign
Director, US Lung Cancer Franchise
Novartis Pharmaceuticals
06.2012 - 08.2015
- Led US commercial team in the development and execution of the lung cancer franchise marketing strategy
- Direct line management and P&L responsibility
- Launched first NSCLC targeted therapy for Novartis and delivered significant volume growth and share gains for Zykadia
Director of Marketing
Forest Laboratories
08.2011 - 06.2012
- Brand lead for Lynzess with responsibility for professional promotions, e-marketing and peer to peer marketing strategy, Advisory Boards, Thought Leader development and speaker training
- Direct line management and executed co-promotion strategy and go to market readiness with Ironwood Pharma
Senior Brand Manager
Novartis Pharmaceuticals
- 03.2011
- Professional promotions Lead and multicultural marketing lead for Reclast
- Led co-promotion efforts with Noven Pharmaceuticals
Business Relationship Manager – Brand Managed Markets
Novartis Pharmaceuticals
- 03.2011
- Developed and maintained relationships with key Novartis Managed Markets/Government Affairs contacts
- Spearheaded product reimbursement/access strategies and related to local, regional and national formulary wins
- Co-led Exelon Patch pricing strategy
Product Manager, Trileptal (Epilepsy)
Novartis Pharmaceuticals
- 03.2011
- Led Trileptal through LOE, implementing DAW initiative, resulting in protecting significant revenue
Senior Analyst, Business Analysis
Novartis Pharmaceuticals
- 03.2011
- Led primary and secondary research and analytics for the Neuroscience franchise
Neuroscience Sales Specialist
Novartis Pharmaceuticals
- 03.2011
- Specialty sales specialists in upstate New York
Senior Brand Manager
Novartis Pharmaceuticals
03.2023 - 03.2011
- Professional promotions lead for Tekturna, Tekamlo and Amturnide brands
- Led Tekamlo and Amturnide launches
Staff Attorney - Criminal Defense Litigator
Bronx Defenders and Public Defender Service
09.1996 - 10.1999
- Represented juveniles and adults charged with felony and misdemeanor crimes in Washington D.C
- And Bronx, NY
Education
BACHELOR OF ARTS - COMMUNICATIONS
ClaRK ATLANTA UNIVERSITY
05.1993
JURIS DOCTOR -
LOYOLA UNIVERSITY, SCHOOL OF LAW
05.1996
Skills
- Executive Leadership Experience
- Strategic Commercialization Leadership
- P&L Management and Revenue Growth
- Cross-Functional Leadership and Engagement
- Strong Interpersonal Communication
- Equity-Focused Initiatives
- Strategic Negotiation Skills
- Employee motivation and performance
Accomplishments
- Healthcare Businesswomen's Association Luminary, 2020 (Merck)
- Healthcare Businesswomen's Association Luminary, 2023 (BMS)
Additional Leadership Activities
- NJ Bio, Board Member
- Healthcare Businesswomen's Association, Board Member
- Newark Academy, Board of Trustees
- Executive Leadership Council, Member
Timeline
Senior Brand Manager
Novartis Pharmaceuticals
03.2023 - 03.2011
Senior Vice President, US Oncology and Global Strategy
Bristol Myers Squibb
05.2021 - Current
Vice President, Commercial Operations US Oncology
Merck Sharp & Dohme
06.2016 - 07.2021
Senior Director of Marketing
Heron Therapeutics
08.2015 - 06.2016
Director, US Lung Cancer Franchise
Novartis Pharmaceuticals
06.2012 - 08.2015
Director of Marketing
Forest Laboratories
08.2011 - 06.2012
Pharmaceutical Sales Representative
Abbott, Pharmacia, Johnson and Johnson
11.1999 - 03.2023
Staff Attorney - Criminal Defense Litigator
Bronx Defenders and Public Defender Service
09.1996 - 10.1999
JURIS DOCTOR -
LOYOLA UNIVERSITY, SCHOOL OF LAW
Senior Vice President, US Oncology and Global Stra
Bristol Myers Squibb
Senior Vice President and General Manager, US Hematology and Cell Therapy
Bristol Myers Squibb
- Current
Senior Vice President and Chief of Staff, Office of the Chairman and CEO
Bristol Myers Squibb
- Current
Senior Vice President, US Oncology
Bristol Myers Squibb
- Current
Associate Vice President, Global Human Health - Genitourinary Cancers
Merck Sharp & Dohme
- 07.2021
Executive Director, Global Human Health, Women's Cancers
Merck Sharp & Dohme
- 07.2021
Director, Women's Cancer Immunotherapy
Merck Sharp & Dohme
- 07.2021
Associate Director, Zykadia
Novartis Pharmaceuticals
- 08.2015
Associate Director, Tasigna
Novartis Pharmaceuticals
- 08.2015
Senior Brand Manager
Novartis Pharmaceuticals
- 03.2011
Business Relationship Manager – Brand Managed Markets
Novartis Pharmaceuticals
- 03.2011
Product Manager, Trileptal (Epilepsy)
Novartis Pharmaceuticals
- 03.2011
Senior Analyst, Business Analysis
Novartis Pharmaceuticals
- 03.2011
Neuroscience Sales Specialist
Novartis Pharmaceuticals
- 03.2011
BACHELOR OF ARTS - COMMUNICATIONS
ClaRK ATLANTA UNIVERSITY
Similar Profiles
CHRISTIAN ROSKERCHRISTIAN ROSKER
Medical Director Oncology & Cell Therapies at Bristol-Myers SquibbMedical Director Oncology & Cell Therapies at Bristol-Myers Squibb
Rosetta Dujat des Allimes RuizRosetta Dujat des Allimes Ruiz
Senior Clinical Site Monitor, at Bristol-Myers Squibb CompanySenior Clinical Site Monitor, at Bristol-Myers Squibb Company
Sujit GaddampallySujit Gaddampally
Manager - II - Regulatory Portfolio Manager at Bristol Myers SquibbManager - II - Regulatory Portfolio Manager at Bristol Myers Squibb
Siddharth SinghSiddharth Singh
Pharmaceutical Manufacturing Operator at Bristol Myers SquibbPharmaceutical Manufacturing Operator at Bristol Myers Squibb
Isely NoelIsely Noel
Order Processing Specialist at Crate and BarrelOrder Processing Specialist at Crate and Barrel